The stock of Instem PLC (LON:INS) is a huge mover today! The stock decreased 0.43% or GBX 0.95 on November 22, hitting GBX 218.05. About 7,342 shares traded hands or 52.55% up from the average. Instem PLC (LON:INS) has declined 6.41% since April 21, 2016 and is downtrending. It has underperformed by 10.97% the S&P500.
The move comes after 9 months negative chart setup for the GBX 34.21 million company. It was reported on Nov, 22 by Barchart.com. We have GBX 211.51 PT which if reached, will make LON:INS worth GBX 1.03 million less.
More news for Instem PLC (LON:INS) were recently published by: Marketwatch.com, which released: “Instem buys Logos Technologies” on May 13, 2013. Globenewswire.com‘s article titled: “Bioinformatics Markets: Genomic Sequencing, Drug Design & Proteomics – Global …” and published on December 10, 2015 is yet another important article.
Instem plc is a supplier of information technology applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The company has a market cap of 34.21 million GBP. The Firm is engaged in Global Life Sciences operations. It currently has negative earnings. The Company’s lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.